Roche blood test could help ‘personalise’ cancer immunotherapy – Nasdaq
Nasdaq |
Roche blood test could help 'personalise' cancer immunotherapy
Nasdaq Evidence shows that tumours with more mutations are more likely to respond to immunotherapy, Roche said, adding that it hopes the new test will improve measuring TMB, particularly when invasive biopsies are not feasible. There are no such blood tests … Roche blood test could help 'personalize' cancer immunotherapy … Immunooncology: Roche presents blood biomarker test |
